The varicella vaccine is mainly for pediatric use; however, it can also be used among adults if they are not vaccinated and have not yet contracted chickenpox.
Belonging to the compulsory vaccinations of the pediatric age, the varicella vaccine is available on the market both in single formulation and in the combined vaccine preparation MPRV.
Carried out by intramuscular injection, the administration of the varicella vaccine is divided into two dosages: in children, these two dosages are dated to the 14th month, the first, and to 5-6 years, the second; in adults, on the other hand, they are usually closer together (a time span of 4 weeks between one dose and the next is sufficient).
Example of a live attenuated vaccine, the varicella vaccine is a drug with reduced adverse effects (the most common are minor clinical disturbances) and effective.
Currently, the varicella vaccine is subject to the vaccination obligation established in the summer of 2017; consequently, it is mandatory for all newborns.
On the market, the varicella vaccine is available both in single formula, and in combination with measles, mumps and rubella vaccines, in what is the combined vaccine preparation also known as MPRV vaccine (Measles-Mumps-Rubella-Varicella ).
